Company intelligence / Profile preview

Imagen

New York, New York, United Statesimagen.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Imagen provides an FDA-cleared, AI-powered diagnostic imaging platform for primary care practices. Their solutions enable on-site screening and testing for early disease detection with demonstrated improvements in clinical outcomes such as reduced life-threatening misses and increased detection rates for conditions like aortic atherosclerosis.

Therapeutic areas: Other
Modalities: DeviceAI software (for diagnostic imaging)
Industry: Medical Imaging

Partnerships

Partnerships with primary care practices to deploy their diagnostics-as-a-service platform

Beyond the preview

Go deeper on Imagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imagen.

Explore the full profile